ストックスクリーナーアプリを入手
5.62
0.36%
0.02
前日終値:
$5.60
開ける：
$5.84
24時間の取引高:
19,539
Relative Volume:
0.39
時価総額：
$62.66M
収益：
$2.09M
当期純損益:
$-5.28M
株価収益率:
-8.3881
EPS:
-0.67
ネットキャッシュフロー:
$-3.64M
1週間 パフォーマンス:
-1.75%
1か月 パフォーマンス:
+11.73%
6か月 パフォーマンス:
+18.82%
1年 パフォーマンス:
+19.07%
1日の値動き範囲:
$5.54
$5.84
1週間の範囲:
$5.54
$6.00
52週間の値動き範囲:
$3.7223
$11.78
Nutriband Inc Stock (NTRB) Company Profile
NTRB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
5.62 | 63.80M | 2.09M | -5.28M | -3.64M | -0.67 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-22 | 開始されました | Noble Capital Markets | Outperform |
Nutriband Inc (NTRB) 最新ニュース
Nutriband (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances - The Globe and Mail
Nutriband Expands Market Presence Through Strategic Health Industry Partnerships - citybuzz -
Nutriband (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch - The Globe and Mail
Nutriband Develops Innovative Abuse-Deterrent Fentanyl Patch Amid Opioid Crisis Regulatory Changes - citybuzz -
Nutriband (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape - The Globe and Mail
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - ACCESS Newswire
(NTRB) Trading Report - news.stocktradersdaily.com
Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021 - ACCESS Newswire
Nutriband (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting Milestones, Commercialization Goals - Barchart.com
Examining Nutriband Inc (NTRB) more closely is necessary - uspostnews.com
A Tale of Resilience: Nutriband Inc Amid Stock Market Turbulence - investchronicle.com
Nutriband CEO Publishes Letter to Shareholders - GlobeNewswire
Nutriband (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare - The Globe and Mail
Nutriband (NTRB) Highlights Key Milestones and Future Goals Amid - GuruFocus
Nutriband Inc. (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue - marketscreener.com
Nutriband CEO Publishes Letter to Shareholders | NTRB Stock News - GuruFocus
Nutriband projects strong sales for abuse-deterrent patches - Investing.com Australia
ForexTV | Small Business Resources - ForexTV
Nutriband Full Year 2025 Earnings: Misses Expectations - Yahoo Finance
Nutriband Inc reports results for the quarter ended January 31Earnings Summary - TradingView
NutriBand Inc. SEC 10-K Report - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
Should You Buy, Sell or Hold Amazon Stock Before Q1 Earnings? - The Globe and Mail
Why Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Big Oil Could Trim Buybacks After Price Rout - The Globe and Mail
Why Nutriband (NASDAQ: NTRB) Is ‘One To Watch’ - Barchart.com
Nutriband Inc. Provides Update on Seven-for-Six Forward Stock Split - ACCESS Newswire
Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services - ACCESS Newswire
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission - ACCESS Newswire
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st - ACCESS Newswire
Nutriband Inc. Announces $8.4M Private Placement - ACCESS Newswire
Is Disney Stock a Buy Now as Trump Tones Down Trade War Rhetoric? - The Globe and Mail
Nutriband (NASDAQ: NTRB): Building A Moat Around Abuse-Deterrent Drug Delivery - Barchart.com
(NTRB) Investment Report - news.stocktradersdaily.com
Nutriband (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery - The Globe and Mail
Nutriband Strengthens Intellectual Property Portfolio for Abuse-Deterrent Drug Delivery - citybuzz -
Stocks in play: BioVaxys Technology Corp - The Globe and Mail
Nutriband (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One To Watch’ - Barchart.com
Nutriband Advances Opioid Safety with Innovative AVERSA Technology - citybuzz -
Nutriband (NTRB) Achieves Key Patent Approval in Macao for AVERS - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology | NTRB Stock News - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology - GlobeNewswire
Nutriband secures Macao patent for drug abuse deterrent tech By Investing.com - Investing.com South Africa
Nutriband Receives Patent for Abuse, Misuse Deterrent Transdermal Systems in Macao - marketscreener.com
Nutriband Inc (NTRB) 財務データ
収益
当期純利益
現金流量
EPS
1.54%
7.58%
大文字化:
|
ボリューム (24 時間):